SAShadia Al-Bahlani

Shadia Al-Bahlani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shadia Al-Bahlani has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Buthaina Al-Dhahli

    Department of Biomedical Science, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

    3 shared publications
  • Kawther Al-Adawi

    Department of Pathology, College of Medicine and Health Sciences, Sultan Qaboos University, PC 123, Al Khoud, Oman

    2 shared publications
  • Shadia S. Al-Sinawi

    Department of Pathology, Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman

    2 shared publications
  • Abdurahman Al-Nabhani

    Department of Pathology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

    1 shared publication
  • Amani Al-Kalbani

    Department of Allied Health Sciences, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

    1 shared publication
  • Anjum H. A. Osman

    Oncology Unit, Department of Medicine, Sultan Qaboos University Hospital, Sultan Qaboos University, Muscat, Oman

    1 shared publication

Latest Publications

  • Open Access

    E2F-1–Akt1 Interaction as Precursor to Cisplatin-induced Apoptosis in Triple-negative Breast Cancer Cells

    by Samiya Al-Jaaidi, Buthaina Al-Dhahli, Asma Al Sibani, Thraia Al Harthi, Hajar Al Ghafri, Shadia Al-Bahlani

    We aimed to investigate the expression levels and interaction between E2F-1 and Akt1 in triple-negative breast cancer (TNBC) cells, and whether cisdiamminedichloroplatinum (II) (cisplatin) could influence such an interaction. A batch of MDA-MB-321 breast cancer cells were treated with increasing concentrations of cisplatin (2.5-40 μM) for 24 hours. Additional cells from the same source were used for control experiments. Cisplatin-induced apoptosis was confirmed biochemically using cleaved polymerase and flow cytometry analysis, and morphologically using hematoxylin and eosin staining, Hoechst staining, and scanning electron microscopy. Caspase-3 cleavage, an indicator of apoptotic induction, was measured by immunofluorescence. A western blot test was used to investigate the effects of cisplatin on E2F-1 and Akt1 expressions, while their co-localization and interaction were detected using immunofluorescence and immunoprecipitation, respectively. A western blot analysis revealed an increase in E2F-1 and a decrease in Akt1 expression with increasing concentration of cisplatin, compared to untreated cells. Merged E2F-1 and Akt1 immunosignals observed by immunofluorescence demonstrated that cisplatin-treated cells exhibited co-localization of immunosignals in clusters and with increased intensity in the cytoplasm. Immunoprecipitation and western blot analysis results further confirmed the association between E2F-1 and Akt1, indicating a potential interaction between the two proteins in MDA-MB-231 cells. Our findings suggest a potential interaction between E2F-1 and Akt1, which in turn could be the precursor for the cisplatin-induced apoptosis in TNBC cells. Further studies are needed to determine whether this interaction occurs directly or via an intermediate protein.

  • Open Access

    Malformin-A1 (MA1) Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin-Induced Apoptosis

    by Nada Abdullah, Yahya Tamimi, Sergey Dobretsov, Najwa Al Balushi, Jalila Alshekaili, Hamed Al Balushi, Mahmood Al Kindi, Syed Imran Hassan, Shadia Al Bahlani, Benjamin K. Tsang, et al.

    High-grade epithelial ovarian cancer is a fatal disease in women frequently associated with drug resistance and poor outcomes. We previously demonstrated that a marine-derived compound MalforminA1 (MA1) was cytotoxic for the breast cancer cell line MCF-7. In this study, we aimed to examine the effect of MA1 on human ovarian cancer cells. The potential cytotoxicity of MA1was tested on cisplatin-sensitive (A2780S) and cisplatin-resistant (A2780CP) ovarian cancer cell lines using AlamarBlue assay, Hoechst dye, flow cytometry, Western blot, and RT-qPCR. MA1 had higher cytotoxic activity on A2780S (IC50 = 0.23 µM) and A2780CP (IC50 = 0.34 µM) cell lines when compared to cisplatin (IC50 = 31.4 µM and 76.9 µM, respectively). Flow cytometry analysis confirmed the cytotoxic effect of MA1. The synergistic effect of the two drugs was obvious, since only 13% of A2780S and 7% of A2780CP cells remained alive after 24 h of treatment with both MA1 and cisplatin. Moreover, we examined the expression of bcl2, p53, caspase3/9 genes at RNA and protein levels using RT-qPCR and Western blot, respectively, to figure out the cell death mechanism induced by MA1. A significant down-regulation in bcl2 and p53 genes was observed in treated cells compared to non-treated cells (p < 0.05), suggesting that MA1 may not follow the canonical pathway to induce apoptosis in ovarian cancer cell lines. MalforminA1 showed promising anticancer activity by inducing cytotoxicity in cisplatin-sensitive and cisplatin-resistant cancer cell lines. Interestingly, a synergistic effect was observed when MA1 was combined with cisplatin, leading to it overcoming its resistance to cisplatin.


  • Correlation of expression of Akt1 and E2F1 and their phosphorylated forms in breast cancer patients with clinicopathological parameters

    by Shadia M. Al-Bahlani, Ritu Lakhtakia, Samiya S. Al-Jaaidi, Shadia S. Al-Sinawi, Shaymaa G. Abd-Elmoety, Murtadha Al-Khabori, Anjum H. A. Osman, Khalid Al-Baimani, Asem A. Shalaby

    Breast cancer is the leading cancer worldwide among women. Traditional clinicopathological prognostic and predictive markers need refining to improve clinical outcomes. This study explored the association between traditional clinicopathological factors and the expression of Akt1 and E2F1 transduction proteins and their phosphorylated forms in breast cancer, to determine their value as novel biomarkers and potential therapeutic targets. Tumor tissues from 94 female breast cancer patients were examined for immunophenotypic expression of total Akt1, pAkt1 (Serine 473), pAkt1 (Threonine 308), total E2F1, pE2F1 (Thr433) and pE2F1 (Ser337). The expression of pAkt1 (Ser473) was significantly associated with ER/PR positive status and total E2F1 with older age (> 50), lymph node involvement and HER2 positivity. There was a significant association between triple negative cancers and total and pAkt1 (Thr308). pAkt1 (Ser473) showed an inverse relationship with Luminal B cancers and pE2F1 (Thr433) showed an inverse association with triple negative cancers. Higher expression of pE2F1 (Ser337) was associated with better OS. Both pAkt1 (Ser473 and Thr308) proteins showed significant association with poorer patient outcomes. E2F1 (Ser337) showed a significant positive correlation with response to chemotherapy. The study suggests that a pAkt1−/pE2F1+ phenotype could indicate an opportunity to minimize chemotherapeutic options in older women; conversely a pAkt1+/pE2F1− phenotype could prompt a more aggressive regimen. Further exploration of this phenotype in younger women with breast cancer and triple-negative breast cancers is warranted.


  • Open Access

    A review of the prevalence of COVID-19 in the Arab world

    by Nasar Alwahaibi, Muna Al-Maskari, Buthaina Al-Dhahli, Halima Al-Issaei, Shadia Al-Bahlani

    Introduction: Coronavirus disease 2019 (COVID-19) is a rapidly spreading disease worldwide. It is a real test for all health authorities including Arab countries. In this review, we aimed to assess the prevalence of COVID-19 in the Arab world. In addition, to compare the findings of this study with other top affected countries. Methodology: We searched for official websites from the Ministries of Health and other official sources in all 22 Arab countries. Medline, Science Direct and Google Scholar websites were also used to search for COVID-19, 2019 novel coronavirus, SARS-CoV-2 and coronavirus. The time period was from 1 January 2020 to 31 May 2020. Results: As of May 31, 2020, COVID-19 has caused 290,428 confirmed cases, 3,696 deaths and 157,886 cured cases in all Arab countries. In terms of confirmed cases, Saudi Arabia followed by Qatar, UAE, Kuwait and Egypt have the highest reported cases. However, the total number of deaths was dominant in Egypt, followed by Algeria, Saudi Arabia, Sudan and UAE. In comparison to other non-Arab countries and confirmed cases, Arab countries come fourth after USA, Brazil and Russia. In terms of death, the Arab world is not listed as the top ten affected countries as only scored eight deaths per million have been recorded. Conclusions: Most Arab countries took some serious early steps to minimize the outbreak of COVID-19. At the moment, controlling the source of infection, the route of transmission and taking care of infected patients are the main challenges for health authorities in all Arab countries.


  • Open Access

    Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway

    by Shadia Al-Bahlani, Ikram A. Burney, Buthaina Al-Dhahli, Safiya Al-Kharusi, Fakhra Al-Kharousi, Amani Al-Kalbani, Ikhlas Ahmed

    Background: Cisplatin (CDDP) is an effective anticancer drug for Gastric cancer (GC) that induces apoptosis by altering pro- (p53) and anti-apoptotic (Akt and NFkB) proteins; however, chemoresistance remains a big challenge. Additional compounds with promising anticancer effects such as AKBA (Acetyl-keto-beta boswellic acid) may overcome the resistance. However, its role in CDDP-induced apoptosis in GC has not been studied. This study aimed to examine the effectiveness of AKBA on p53-mediated, CDDP-induced apoptosis in GC cells. AGS and NCI-N87 cells were treated with different concentrations (0, 25, 50, 100 μM) of CDDP and/or AKBA. Methods: P53, Akt and NFkB proteins and apoptosis were assessed by Western blot and flow cytometry. The role of p53 was determined by inhibiting its function via the siRNA approach. Results: The results revealed that CDDP and AKBA significantly increased p53 content in both cells, while Akt and NFkB were significantly decreased. Both compounds significantly induced apoptosis in a dose-dependent manner. AKBA sensitized GC cells to CDDP-induced apoptosis by altering the protein expression. P53 downregulation affected Akt and NFkB proteins with a slight increase in apoptosis induction in the combination treated groups. Conclusions: Altogether, our findings suggest that AKBA enhances GC cell sensitivity to CDDP-induced apoptosis via the p53 pathway.


  • Open Access

    Triple-Negative Breast Cancer, Cisplatin and Calpain-1

    by Shadia Al-Bahlani, Samiya Al-Jaaidi

    Chemo-resistance of breast cancer is a major obstacle for successful treatment and is mainly represented as a defect in apoptosis. The differential effects of platinum-based drugs (PBDs) were assessed on breast cancer cell ultrastructure. Three representative cells, including triple-negative breast cancer (TNBC), were treated with different concentrations and timings of cisplatin, carboplatin, and oxaliplatin. Changes on cell surface and ultrastructure were detected by scanning electron microscope (SEM) and transmission electron microscope (TEM). In addition, using advanced techniques in molecular biology, we demonstrated that calpain-1 plays an essential role in modulating breast cancer cell sensitivity to cisplatin-induced apoptosis. We also showed that the correlation of its expression to the proliferating/apoptotic index using immunohistochemical staining in TNBC tissue was variable. Exploring new pathways will help in overcoming chemo-resistance in breast cancer cells.

  • Cisplatin Induces Apoptosis Through the Endoplasmic Reticulum-mediated, Calpain 1 Pathway in Triple-negative Breast Cancer Cells

    by Shadia M. Al-Bahlani, Khadija H. Al-Bulushi, Zaina M. Al-Alawi, Nadia Y. Al-Abri, Zuweina R. Al-Hadidi, Shaikha S. Al-Rawahi


  • Fatty acid synthase regulates the chemosensitivity of breast cancer cells to cisplatin-induced apoptosis

    by Shadia Al-Bahlani, Hanaa Al-Lawati, Moza Al-Adawi, Nadia Al-Abri, Buthaina Al-Dhahli, Kawther Al-Adawi

    Fatty acid synthase (FASN) is a key enzyme in fat biosynthesis that is over-expressed in advanced breast cancer stages. Cisplatin (CDDP) is a platinum-based drug used in the treatment of certain types of this disease. Although it was shown that FASN inhibition induced apoptosis by enhancing the cytotoxicity of certain drugs in breast cancer, its role in regulating the chemosensitivity of different types of breast cancer cells to CDDP-induced apoptosis is not established yet. Therefore, two different breast cancer cell lines; triple negative breast cancer (TNBC; MDA-MB-231) and triple positive breast cancer (TPBC; BT-474) cells were used to examine such role. We show that TNBC cells had naturally less fat content than TPBC cells. Subsequently, the fat content increased in both cells when treated with Palmitate rather than Oleate, whereas both fatty acids produced apoptotic ultra-structural effects and attenuated FASN expression. However, Oleate increased FASN expression in TPBC cells. CDDP decreased FASN expression and increased apoptosis in TNBC cells. These effects were further enhanced by combining CDDP with fatty acids. We also illustrate that the inhibition of FASN by either siRNA or exogenous inhibitor decreased CDDP-induced apoptosis in TPBC cells suggesting its role as an apoptotic factor, while an opposite finding was observed in TNBC cells when siRNA and fatty acids were used, suggesting its role as a survival factor. To our knowledge, we are the first to demonstrate a dual role of FASN in CDDP-induced apoptosis in breast cancer cells and how it can modulate their chemosensitivity.


  • Open Access

    Calpain-1 Expression in Triple-Negative Breast Cancer: A Potential Prognostic Factor Independent of the Proliferative/Apoptotic Index

    by Shadia M. Al-Bahlani, Ruqaya M. Al-Rashdi, Shiyam Kumar, Shadia S. Al-Sinawi, Maiya A. Al-Bahri, Asem A. Shalaby

    Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer in which calpain system plays an important role in its cellular processes including apoptosis and proliferation. Although such roles have been assessed in tumor pathogenesis, the correlation of its expression to the proliferating/apoptotic index has not been studied yet. Immunohistochemical staining of calpain-1 was performed on paraffin-embedded tissues to correlate its expression with clinicopathological variables and outcome. The proliferation activity was determined by calculating the percentage of cells expressing the Ki-67 antigen. The apoptotic index was assessed morphologically and biochemically using Haematoxylin & Eosin method and Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay, respectively. Calpain-1 was significantly expressed in TNBC tissues varying from low to high with a significant correlation to lymph node status but not with the other clinicopathological variables, suggesting its role as a prognostic factor. In addition, a positive correlation was found between both apoptotic counts assays (P<0.001, r=0.547) as well as with proliferation (P=0.045). Calpain-1 expression had no significant correlation with either proliferation (P=0.29) or apoptotic indices (P=0.071 and P=0.100). Determining calpain-1 expression may provide relevant prognostic value for TNBC cancer patients.


  • Open Access

    Platinum-Based Drugs Differentially Affect the Ultrastructure of Breast Cancer Cell Types

    by Shadia Al-Bahlani, Buthaina Al-Dhahli, Kawther Al-Adawi, Abdurahman Al-Nabhani, Mohamed Al-Kindi

    Breast cancer (BC) is the most common cause of cancer-related death worldwide. Although platinum-based drugs (PBDs) are effective anticancer agents, responsive patients eventually become resistant. While resistance of some cancers to PBDs has been explored, the cellular responses of BC cells are not studied yet. Therefore, we aim to assess the differential effects of PBDs on BC ultrastructure. Three representative cells were treated with different concentrations and timing of Cisplatin, Carboplatin, and Oxaliplatin. Changes on cell surface and ultrastructure were detected by scanning (SEM) and transmission electron microscope (TEM). In SEM, control cells were semiflattened containing microvilli with extending lamellipodia while treated ones were round with irregular surface and several pores, indicating drug entry. Prolonged treatment resembled distinct apoptotic features such as shrinkage, membrane blebs, and narrowing of lamellipodia with blunt microvilli. TEM detected PBDs’ deposits that scattered among cellular organelles inducing structural distortion, lumen swelling, chromatin condensation, and nuclear fragmentation. Deposits were attracted to fat droplets, explained by drug hydrophobic properties, while later they were located close to cell membrane, suggesting drug efflux. Phagosomes with destructed organelles and deposits were detected as defending mechanism. Understanding BC cells response to PBDs might provide new insight for an effective treatment.